Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G/A filed Mar 12, 2025

Name: Aspire Biopharma Holdings, Inc. SCHEDULE 13G/A (0001493152-25-010043)
Creator: Aspire Biopharma Holdings, Inc.
Published: 2025-03-12

Form type: SCHEDULE 13G/A
Filing date: Mar 12, 2025
Accession number: 0001493152-25-010043
Filer: Aspire Biopharma Holdings, Inc. (CIK 1847345)